6.86
-0.20 (-2.83%)
-0.20 (-2.83%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 902,748 |
|
|||||
| News | (1) | ||||||
| Day High | 7.12 | Low High |
|||||
| Day Low | 6.79 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.20 | -2.83% | 6.86 | 00:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.08 | 6.79 | 7.12 | 6.86 | 7.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,974 | 902,748 | $ 6.93 | $ 6,257,034 | - | 3.27 - 7.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:03:28 | 4 | $ 6.86 | USD |
Period:
Draw Mode:
Catalyst Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 707.39M | 103.12M | 95.58M | $ 119.07M | $ 37.10M | 0.71 | 17.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -512.00k | 9.30% |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.35 | 7.42 | 6.79 | 6.99 | 869,793 | -0.49 | -6.67% |
| 1 Month | 6.28 | 7.58 | 6.07 | 7.08 | 980,181 | 0.58 | 9.24% |
| 3 Months | 5.04 | 7.58 | 4.81 | 6.15 | 904,909 | 1.82 | 36.11% |
| 6 Months | 5.51 | 7.58 | 4.81 | 5.89 | 940,557 | 1.35 | 24.5% |
| 1 Year | 3.578 | 7.58 | 3.27 | 4.80 | 1,284,636 | 3.28 | 91.73% |
| 3 Years | 2.71 | 7.67 | 1.85 | 4.32 | 1,753,380 | 4.15 | 153.14% |
| 5 Years | 1.09 | 7.67 | 1.01 | 3.92 | 1,422,580 | 5.77 | 529.36% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with the lambert-eaton myasthenic syndrome. |
